VRSK vs SPGI vs CME Stock Comparison

Verisk Analytics, S&P Global and Cme Prices as of Nov 13, 2026 Peers: Industry group
VRSK Verisk Analytics, Inc.
$207.82 +15.1% 1M -4.5% 1Y
Market cap
$27.52B
P/E
31.3x
Revenue (TTM)
$3.18B
Div. yield
–
Financial Data and Analytics Financial Services
1 win
SPGI S&P Global Inc.
$473.60 +15.9% 1M -5.8% 1Y
Market cap
$136.83B
P/E
27.4x
Revenue (TTM)
$17.21B
Div. yield
0.01%
Financial Data and Analytics Financial Services
3 wins
CME Cme Group Inc.
$317.97 +11.3% 1M +12.1% 1Y
Market cap
$114.16B
P/E
25.9x
Revenue (TTM)
$6.97B
Div. yield
–
Exchanges Financial Services
7 wins

Head to Head

11 decided of 12

Cme leads on 7 of the 12 questions below (Cme 7, S&P Global 3, Verisk Analytics 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionVRSKSPGICMELeader
Larger companyMarket capitalisation $27.52B $136.83B $114.16B SPGI
Cheaper on earningsLower P/E, profitable companies only 31.3x 27.4x 25.9x CME
Cheaper on forward earningsLower price / next fiscal year consensus EPS 26.1x 25.0x 27.1x SPGI
Faster revenue growthRevenue growth, trailing twelve months +4.9% +18.2% +9.0% SPGI
More profitableNet margin, trailing twelve months 27.7% 29.0% 63.3% CME
Better return on capitalReturn on invested capital 31.9% 14.9% 11.7% VRSK
Less leveragedLower net debt / EBITDA 2.3x 1.2x 0.2x CME
Higher dividend yieldTrailing dividend yield 0.00% 0.01% 0.00% –
Better 1-year returnPrice return, last 12 months -4.5% -5.8% +12.1% CME
Better 5-year returnAnnualised price return, 5 years -0.8%/yr +0.9%/yr +7.2%/yr CME
Less volatileAnnualised volatility, 1 year 36.4% 30.6% 25.5% CME
Higher overall scoreMean of the five percentile scores vs peers 54/100 61/100 63/100 CME

Percentile Scorecard

VRSKSPGICME

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisVRSKSPGICME
Valuation 37 #699 of 1108 32 #751 of 1108 53 #63 of 134
Growth 40 #540 of 897 75 #229 of 897 30 #59 of 84
Profitability 95 #46 of 922 91 #80 of 922 87 #12 of 88
Financial Health 27 #798 of 1098 57 #468 of 1098 51 #75 of 151
Shareholder Returns 70 #230 of 758 48 #397 of 758 92 #5 of 49
Overall 54 61 63
  • VRSK ranked among 1,197 companies in Financial Services
  • SPGI ranked among 1,197 companies in Financial Services
  • CME ranked among 158 companies in Capital Markets

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodVRSKSPGICMESPY
1 month +15.1%+15.9%+11.3% -2.0%
3 months +14.4%+13.1%+17.9% -2.8%
6 months +27.8%+17.5%+6.4% +2.0%
Year to date -7.1%-9.4%+16.4% +10.6%
1 year -4.5%-5.8%+12.1% +12.2%
3 years -12.7%+17.3%+50.2% +68.1%
3 years, per year -4.4%+5.5%+14.5% +18.9%
5 years -3.9%+4.5%+41.4% +61.4%
5 years, per year -0.8%+0.9%+7.2% +10.1%
10 years +150.0%+277.5%+178.0% +248.5%
10 years, per year +9.6%+14.2%+10.8% +13.3%

Risk

MeasureVRSKSPGICMESPY
Volatility, 1Y 36.4%30.6%25.5% 13.6%
Downside volatility, 1Y 36.8%35.5%27.2% 13.9%
Beta vs S&P 500, 1Y -0.580.37-0.30 1.00
Return / volatility, 1Y -0.12-0.190.48 0.90
Max drawdown, 5Y -51.2%-40.2%-33.1% -25.4%
From 52-week high -7.7%-13.3%-2.6% -3.2%
52-week high $225.07$546.35$326.46 $779.14
52-week low $156.84$386.35$218.58 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleVRSKSPGICME
P/E now vs peer median 30.5xmedian 14.9x 27.7xmedian 14.9x 25.8xmedian 42.3x
P/S now vs peer median 8.4xmedian 3.2x 8.0xmedian 3.2x 16.3xmedian 3.9x
EV/EBITDA now vs peer median 17.5xmedian 6.3x 16.2xmedian 6.3x 23.4xmedian 12.7x
P/FCF now vs peer median 24.2xmedian 10.5x 23.5xmedian 10.5x 26.2xmedian 16.5x
P/B now vs peer median -23.9xmedian 1.3x 6.9xmedian 1.3x 4.3xmedian 3.7x
PEG now vs peer median 1.20median 0.89 0.93median 0.89 1.88median 0.52

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsVRSKSPGICME
Revenue $3.18B $17.21B $6.97B
Gross profit $2.23B $12.21B $1.37B
Operating income $1.39B $7.77B $4.58B
Net income $879.20M $5.40B $4.42B
Free cash flow $1.10B $5.84B $4.33B
EPS (diluted) $6.80 $17.10 $12.31
Cash & equivalents $556.80M $2.44B $2.20B
Total debt $4.50B $13.06B $3.43B
Shares (diluted) 129.23M 291.60M 358.64M
Enterprise value $23.71B $126.69B $102.50B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricVRSKSPGICME
P/E 30.5x 27.7x 25.8x
P/FCF 24.2x 23.5x 26.2x
P/Operating cash flow 19.5x 22.9x 25.7x
P/S 8.4x 8.0x 16.3x
P/B -23.9x 6.9x 4.3x
P/Tangible book -18.8x 17.4x 4.7x
EV/EBITDA 17.5x 16.2x 23.4x
EV/EBIT 21.9x 19.0x 25.1x
EV/Revenue 9.6x 8.6x 16.5x
EV/FCF 27.8x 25.3x 26.5x
EV/Operating cash flow 22.4x 24.7x 25.9x
PEG (3Y EPS CAGR) 1.20 0.93 1.88

Growth

14 metrics
MetricVRSKSPGICME
Revenue growth (1Y) 4.9% 18.2% 9.0%
Revenue CAGR (3Y) 6.4% 11.9% 9.2%
Gross profit growth (1Y) 5.7% 19.7% 13.2%
Gross profit CAGR (3Y) 7.8% 14.4% 12.5%
Operating income growth (1Y) 3.6% 29.7% 10.1%
Operating income CAGR (3Y) 6.2% 26.4% 12.2%
Net income growth (1Y) -4.6% 18.3% 17.3%
Net income CAGR (3Y) 20.6% 25.3% 13.1%
EPS growth (1Y) 3.3% 23.4% 19.4%
EPS CAGR (3Y) 25.5% 29.9% 13.7%
Operating cash flow growth (1Y) 1.4% 18.5% 6.4%
Operating cash flow CAGR (3Y) 8.9% 19.8% 9.3%
Free cash flow growth (1Y) -1.4% 19.4% 6.1%
Free cash flow CAGR (3Y) 11.0% 20.2% 9.4%

Profitability

14 metrics
MetricVRSKSPGICME
Gross margin 70.2% 70.9% 19.7%
EBITDA margin 55.0% 53.1% 70.4%
Operating margin 43.9% 45.1% 65.7%
Pretax margin 36.3% 43.4% 82.8%
Net margin 27.7% 29.0% 63.3%
FCF margin 34.6% 33.9% 62.1%
Operating cash flow margin 43.0% 34.8% 63.5%
Return on equity – 21.0% 16.6%
Return on assets 19.5% 9.7% 2.3%
Return on invested capital 31.9% 14.9% 11.7%
Return on capital employed 40.5% 16.6% 12.3%
Asset turnover 0.7x 0.3x 0.0x
Cash conversion (OCF / net income) 1.6x 1.1x 1.0x
Stock comp / revenue 1.9% 1.2% 1.4%

Financial Health

11 metrics
MetricVRSKSPGICME
Debt / assets 99.0% 27.2% 1.8%
Debt / equity -4.0x 0.7x 0.1x
Net debt / EBITDA 2.3x 1.2x 0.2x
Debt / FCF 4.1x 2.2x 0.8x
Liabilities / assets 124.5% 58.7% 86.2%
Equity / assets -24.5% 41.3% 13.8%
Interest coverage 6.8x 24.0x 26.2x
Current ratio 1.1x 0.7x 1.0x
Quick ratio 0.9x 0.6x 0.0x
Cash ratio 0.5x 0.3x 0.0x
Altman Z-score 7.12 4.24 0.59

Shareholder Returns

7 metrics
MetricVRSKSPGICME
Dividend yield 0.9% 0.8% 3.1%
Net buyback yield 7.0% 4.8% –
Shareholder yield 7.9% 5.6% 3.1%
Payout ratio (earnings) – 21.2% –
Payout ratio (FCF) – 19.6% –
Dividend growth (1Y) – -1.2% –
Dividend CAGR (3Y) – 0.2% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusVRSKSPGICME
Forward P/E 26.1xFY2026 25.0xFY2026 27.1xFY2026
EPS, next fiscal year $7.96FY2026 $18.93FY2026 $11.75FY2026
EPS growth, next FY +11.2%FY2026 +12.3%FY2026 +4.9%FY2026
EPS growth, the year after +5.3% +12.6% +19.3%
Revenue, next fiscal year $3.33BFY2026 $15.54BFY2026 $7.27BFY2026
Revenue growth, next FY +8.6%FY2026 +1.3%FY2026 +11.6%FY2026
Revenue growth, the year after +6.4% +6.6% +7.0%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersVRSKSPGICME
Held by institutions 97.6% 87.5% 88.9%
Institutions holding 956 2,004 1,694
Change in shares held, QoQ -0.4% +1.6% +0.4%
Institutions buying 489 873 824
Institutions selling 350 877 656
Buyers to sellers 1.40 1.00 1.26

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

VRSKSPGICME
VRSK 1.00 0.58 0.23
SPGI 0.58 1.00 0.22
CME 0.23 0.22 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, VRSK, SPGI and CME?

S&P Global (SPGI) is the largest by market capitalisation: Verisk Analytics (VRSK) $27.52B, S&P Global (SPGI) $136.83B, Cme (CME) $114.16B.

Which stock is cheaper, VRSK, SPGI and CME?

Cme (CME) trades on the lowest price-to-earnings ratio (Verisk Analytics (VRSK) 31.3x, S&P Global (SPGI) 27.4x, Cme (CME) 25.9x). On next year's consensus earnings, S&P Global (SPGI) is cheapest (Verisk Analytics (VRSK) 26.1x, S&P Global (SPGI) 25.0x, Cme (CME) 27.1x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

S&P Global (SPGI) grew revenue fastest over the trailing twelve months: Verisk Analytics (VRSK) +4.9%, S&P Global (SPGI) +18.2%, Cme (CME) +9.0%.

Which company is more profitable?

Cme (CME) has the highest net margin (Verisk Analytics (VRSK) 27.7%, S&P Global (SPGI) 29.0%, Cme (CME) 63.3%). On return on invested capital, Verisk Analytics (VRSK) leads (Verisk Analytics (VRSK) 31.9%, S&P Global (SPGI) 14.9%, Cme (CME) 11.7%).

Which stock has performed better?

Over the past year Cme (CME) returned the most: Verisk Analytics (VRSK) -4.5%, S&P Global (SPGI) -5.8%, Cme (CME) +12.1%. Over five years, Cme (CME) compounded fastest (Verisk Analytics (VRSK) -0.8%/yr, S&P Global (SPGI) +0.9%/yr, Cme (CME) +7.2%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Verisk Analytics (VRSK) 0.00%, S&P Global (SPGI) 0.01%, Cme (CME) 0.00%. Verisk Analytics (VRSK) and Cme (CME) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Cme (CME) has been the steadiest (Verisk Analytics (VRSK) 36.4%, S&P Global (SPGI) 30.6%, Cme (CME) 25.5%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, VRSK, SPGI and CME?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Cme (CME) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.